β2-Adrenergic Receptor Agonists Inhibit the Proliferation of 1321N1 Astrocytoma Cells
Lawrence Toll(Florida Atlantic University), Irving W. Wainer(Cooper Medical School of Rowan University)
Cited by 39
Related Papers
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems
|Pharmacological Reviews|2016|290
(R,S)-Ketamine Metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine Increase the Mammalian Target of Rapamycin Function
|Anesthesiology|2014|115
Activities of mixed NOP and μ‐opioid receptor ligands
|British Journal of Pharmacology|2007|62
Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington’s disease for participants of varying functional disability: a pilot study
|Scientific Reports|2020|38
Cannabinoid Receptor Activation Correlates with the Proapoptotic Action of the β2-Adrenergic Agonist (R,R′)-4-Methoxy-1-Naphthylfenoterol in HepG2 Hepatocarcinoma Cells
|Journal of Pharmacology and Experimental Therapeutics|2012|19